The recent altcoin revival captured investors’ attention, but not all tokens benefited. Aptos, for example, is down on the daily chart. On the other hand, Tradecurve’s prices are trending higher, drawing more decentralized finance (DeFi) enthusiasts.
>>Register for the Tradecurve presale<<
Aptos in the red zone
Aptos recently released the Petra Wallet on Google Play and the Apple App Store. Moreover, the project also introduced the Aptos Improvement Proposal (AIP-10), Move Objects.
The proposal aims to enhance resource control and ownership management performance and storage.
As of July 11, 2023, Aptos changed hands at $7.02.
In the last week of trading, APT prices fell to $6.85 and peaked at $8.19 but mostly remained in the red, losing 14.1%, suggesting overall weakness.
For this reason, analysts are mostly bearish on APT prices, and investors are exploring alternatives.
Tradecurve’s features
Investors are diversifying as Aptos remains under pressure. Tradecurve will be a hybrid exchange combining elements of CEXs and DEXs to offer a borderless trading experience.
The platform will have high leverage, starting at 500:1, negative balance protection, AI-powered trading bots, and a VIP account system.
Tradecurve price performance
In Stage 4 of the Tradecurve presale, TCRV is trading at $0.018, up 80% in the last month. However, TCRV prices will rise 40% in the next presale round.
In all, analysts expect more price gains even after the project launches. As such, investors can consider examining TCRV.
Investors are eager
Tradecurve will allow trading with zero know-your-customer (KYC) requirements with deposited crypto as collateral, giving global access to markets, including the $632 trillion global over-the-counter (OTC) derivatives market. For what the platform is lining up, investors remain bullish.
For more information about the Tradecurve presale:
Click here for the website
Click here to buy TCRV presale tokens
Join our community on Telegram
Disclosure: This content is provided by a third party. crypto.news does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.
Credit: Source link